NEW YORK (GenomeWeb News) – DNA-based nutrition company GenoVive today announced a deal with Bariatric Support to bring GenoVive's weight loss program to Mexico.

GenoVive, based in New Orleans, uses in-home DNA testing to identify an individual's genetic makeup and then customizes diets and exercise plans to help customers lose and manage their weight. Under the terms of the deal, GenoVive and Bariatric may also research how cultural and ethnic differences affect weight gain, loss, and management. Further terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: transcript patterns in drug-resistant cancer cells, function of high-altitude adaption gene, and more.

Monitoring gene expression changes could help sniff out athletes using performance-enhancing drugs, New Scientist says.

The University of Southern California lodges a cross-complaint in its legal dispute with the University of California, San Diego, over a large Alzheimer's disease project.

In PLOS this week: gene fusion in premature ovarian failure, population patterns in the Franciscana dolphin, and more.